allinon72
Full Access Member
Regardless, there are going to be a lot of trucks filling up the used market.
Disclaimer: Links on this page pointing to Amazon, eBay and other sites may include affiliate code. If you click them and make a purchase, we may earn a small commission.
Regardless, there are going to be a lot of trucks filling up the used market.
You're ignoring volume of production. Once the gen 2 trucks start coming off lease in droves, and trust me there will he a LOT of them, the depreciation will be exponential.
The gen 1 started off as a limited production, niche vehicle. Production ramped up for 13 and 14, but was then discontinued. The gen 2 was a mass produced truck from the start because Ford knew they would sell. They were no longer looked at as niche, they were looked at more as a trim level.
I'm not "ignoring volume of production", the market is ignoring it. Used buyers want a "mass produced" 2017 Gen2 a lot more than they want a "rare" 2014, to the tune of $18,000 more going by typical sale prices of 2017s ($58k) vs 2014s ($40k).
I have been called delusional before...in fact I brew beer and named one of my brews "DELUSIONAL INTELLIGENCE"...so,delusional or not...Your calling a Gen1 Shelby Raptor which only 100 per model year were made a MASS produced truck....if so....we should have one of my beers together....
No worries...everyone has their own way of thinking about "value"
Sorry, maybe delusional wasn’t the proper diagnosis. Due to your age, you maybe a good candidate for a drug that just passed the fda made by a company I invested in.
“Acadia's shares perked up today in response to the news that pimavanserin (aka Nuplazid) hit its primary endpoint in a Phase 3 trial known as Harmony. The Harmony trial was designed to evaluate pimavanserin as a treatment for dementia-related psychosis”